Liquid profiling for cancer patient stratification in precision medicine: current status and challenges for successful implementation in standard care

Circulating tumor DNA (ctDNA), accurately described by the term liquid profiling (LP), enables real-time assessment of the tumor mutational profile as a minimally invasive test and has therefore rapidly gained traction, particular for the management of cancer patients. By LP, tumor-specific genetic...

Full description

Saved in:
Bibliographic Details
Main Authors: Haselmann, Verena (Author) , Hedtke, Maren (Author) , Neumaier, Michael (Author)
Format: Article (Journal)
Language:English
Published: July 4, 2022
In: Journal of laboratory medicine
Year: 2022, Volume: 46, Issue: 4, Pages: 225-236
ISSN:2567-9449
DOI:10.1515/labmed-2022-0066
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1515/labmed-2022-0066
Verlag, lizenzpflichtig, Volltext: https://www.degruyterbrill.com/document/doi/10.1515/labmed-2022-0066/html
Get full text
Author Notes:Verena Haselmann, Maren Hedtke and Michael Neumaier
Search Result 1